1Renal and Metabolic Division, The George Institute, University of New South Wales Sydney, Sydney, New South Wales, Australia
2Department of Renal Medicine, Prince of Wales Hospital, Sydney, New South Wales, Australia
3Department of Medicine, University of New South Wales Sydney, Sydney, New South Wales, Australia
4Department of Renal Medicine, Concord Hospital, Sydney, New South Wales, Australia
5Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
6Department of Renal Medicine, Sydney Adventist Hospital, Sydney, New South Wales, Australia
7Department of Neurology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
8Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia
9Statistics Division, The George Institute The George Institute, University of New South Wales Sydney, Sydney, New South Wales, Australia
10Department of Statistics, University of Technology, Sydney, New South Wales, Australia
11Kidney Health Division, National Health and Medical Research Council of Australia Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia
12Department of Renal Medicine, St. George Hospital, Sydney, New South Wales, Australia
13Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia
14Department of Neurology, Prince of Wales Hospital, Sydney, New South Wales, Australia
Correspondence: Prof. Meg J. Jardine, National Health and Medical Research Council of Australia Clinical Trials Centre, University of Sydney, Levels 4–6 Medical Foundation Building, 92-94 Parramatta Rd. Camperdown, NSW, Australia. Email: [email protected]
*The FINESSE Steering Committee members include Meg J. Jardine (Chair), Arun V. Krishnan, Vlado Perkovic, Martin Gallagher, Paul Snelling, Matthew Kiernan, Carmel Hawley, Mangalee Fernando, and Josette Eris.
